Clinical Trial Update: Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®） [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for the recombinant hepatitis E vaccine Hecolin® has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Drugs mentioned

• Hecolin (HEV-239 recombinant vaccine)

Snippet

Sponsor: Jun Zhang | Conditions: Hepatitis E | Phase 4 | Status: COMPLETED